KALARIS THERAPEUTICS, INC. Long-term Purchase Commitment, Minimum Quantity Required
KALARIS THERAPEUTICS, INC. (KLRS) reported Long-term Purchase Commitment, Minimum Quantity Required of 1 Batch for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-10.
Discontinued › Notes
us-gaap:LongTermPurchaseCommitmentMinimumQuantityRequired · last filed 2022-02-10
- KALARIS THERAPEUTICS, INC. long-term purchase commitment, minimum quantity required for fiscal 2021 was 1.00 Batch, a 0.00% change from fiscal 2020.
- KALARIS THERAPEUTICS, INC. long-term purchase commitment, minimum quantity required for fiscal 2020 was 1.00 Batch.
| Period end | Long-term Purchase Commitment, Minimum Quantity Required 12 month |
|---|---|
| 2021-12-31 | 1.00 Batch 10-K · filed 2022-02-10 |
| 2020-12-31 | 1.00 Batch 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |